Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of orexin/hypocretin in dependence and addiction
Ruth Sharf, Maysa Sarhan, Ralph Dileone
Brain Research (2009) Vol. 1314, pp. 130-138
Open Access | Times Cited: 105

Showing 1-25 of 105 citing articles:

The Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors
S P H Alexander, Helen E. Benson, Elena Faccenda, et al.
British Journal of Pharmacology (2013) Vol. 170, Iss. 8, pp. 1459-1581
Open Access | Times Cited: 552
Hypocretin (orexin) facilitates reward by attenuating the antireward effects of its cotransmitter dynorphin in ventral tegmental area
John W. Muschamp, Jonathan A. Hollander, Jennifer L. Thompson, et al.
Proceedings of the National Academy of Sciences (2014) Vol. 111, Iss. 16
Open Access | Times Cited: 238
The lateral hypothalamus as integrator of metabolic and environmental needs: From electrical self-stimulation to opto-genetics
Hans-Rudi Berthoud, Heike Münzberg
Physiology & Behavior (2011) Vol. 104, Iss. 1, pp. 29-39
Open Access | Times Cited: 238
The hypocretins/orexins: integrators of multiple physiological functions
Jingcheng Li, Zhian Hu, Luı́s de Lecea
British Journal of Pharmacology (2013) Vol. 171, Iss. 2, pp. 332-350
Open Access | Times Cited: 229
Role of orexin/hypocretin in reward-seeking and addiction: Implications for obesity
Angie M. Cason, Rachel J. Smith, Pouya Tahsili‐Fahadan, et al.
Physiology & Behavior (2010) Vol. 100, Iss. 5, pp. 419-428
Open Access | Times Cited: 214
Orexin/hypocretin role in reward: implications for opioid and other addictions
Corey Baimel, Selena E. Bartlett, Lih‐Chu Chiou, et al.
British Journal of Pharmacology (2014) Vol. 172, Iss. 2, pp. 334-348
Open Access | Times Cited: 168
Hypocretins Regulate the Anxiogenic-Like Effects of Nicotine and Induce Reinstatement of Nicotine-Seeking Behavior
Ainhoa Plaza‐Zabala, Elena Martín‐García, Luı́s de Lecea, et al.
Journal of Neuroscience (2010) Vol. 30, Iss. 6, pp. 2300-2310
Open Access | Times Cited: 161
International Union of Basic and Clinical Pharmacology. LXXXVI. Orexin Receptor Function, Nomenclature and Pharmacology
Anthony L. Gotter, Andrea L. Webber, Paul J. Coleman, et al.
Pharmacological Reviews (2012) Vol. 64, Iss. 3, pp. 389-420
Closed Access | Times Cited: 154
Orexin/hypocretin receptor signalling: a functional perspective
Christopher S. Leonard, Jyrki P. Kukkonen
British Journal of Pharmacology (2013) Vol. 171, Iss. 2, pp. 294-313
Open Access | Times Cited: 126
Orexin / hypocretin 1 receptor antagonist reduces heroin self‐administration and cue‐induced heroin seeking
Rachel J. Smith, Gary Aston‐Jones
European Journal of Neuroscience (2012) Vol. 35, Iss. 5, pp. 798-804
Open Access | Times Cited: 120
A Selective Orexin-1 Receptor Antagonist Attenuates Stress-Induced Hyperarousal without Hypnotic Effects
Pascal Bonaventure, Sujin Yun, Philip L. Johnson, et al.
Journal of Pharmacology and Experimental Therapeutics (2015) Vol. 352, Iss. 3, pp. 590-601
Open Access | Times Cited: 94
Suvorexant ameliorated sleep disturbance, opioid withdrawal, and craving during a buprenorphine taper
Andrew S. Huhn, Patrick H. Finan, Charlene E. Gamaldo, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 650
Closed Access | Times Cited: 50
Direct Innervation and Modulation of Orexin Neurons by Lateral Hypothalamic LepRb Neurons
Gwendolyn W. Louis, Gina M. Leinninger, Christopher J. Rhodes, et al.
Journal of Neuroscience (2010) Vol. 30, Iss. 34, pp. 11278-11287
Open Access | Times Cited: 107
Forebrain networks and the control of feeding by environmental learned cues
Gorica D. Petrovich
Physiology & Behavior (2013) Vol. 121, pp. 10-18
Open Access | Times Cited: 98
Orexin mediates morphine place preference, but not morphine-induced hyperactivity or sensitization
Ruth Sharf, Douglas J. Guarnieri, Jane R. Taylor, et al.
Brain Research (2009) Vol. 1317, pp. 24-32
Open Access | Times Cited: 96
Orexin receptors as therapeutic drug targets
Anthony L. Gotter, Anthony J. Roecker, Richard Hargreaves, et al.
Progress in brain research (2012), pp. 163-188
Closed Access | Times Cited: 95
Orexin-1 and orexin-2 receptor antagonists reduce ethanol self-administration in high-drinking rodent models
Rachel I. Anderson, Howard C. Becker, Benjamin L. Adams, et al.
Frontiers in Neuroscience (2014) Vol. 8
Open Access | Times Cited: 92
The Hypocretin/Orexin System: An Increasingly Important Role in Neuropsychiatry
Quanhui Chen, Luı́s de Lecea, Zhian Hu, et al.
Medicinal Research Reviews (2014) Vol. 35, Iss. 1, pp. 152-197
Closed Access | Times Cited: 79
Brain orexin promotes obesity resistance
Catherine M. Kotz, Joshua P. Nixon, Tammy A. Butterick, et al.
Annals of the New York Academy of Sciences (2012) Vol. 1264, Iss. 1, pp. 72-86
Open Access | Times Cited: 76
The Effects of Amphetamine and Methamphetamine on the Release of Norepinephrine, Dopamine and Acetylcholine From the Brainstem Reticular Formation
Michela Ferrucci, Fiona Limanaqi, Larisa Ryskalin, et al.
Frontiers in Neuroanatomy (2019) Vol. 13
Open Access | Times Cited: 74
The role of orexin-1 receptor signaling in demand for the opioid fentanyl
Jennifer E. Fragale, Caroline B. Pantazis, Morgan H. James, et al.
Neuropsychopharmacology (2019) Vol. 44, Iss. 10, pp. 1690-1697
Open Access | Times Cited: 68
Selective Fos induction in hypothalamic orexin/hypocretin, but not melanin-concentrating hormone neurons, by a learned food-cue that stimulates feeding in sated rats
Gorica D. Petrovich, Michael Hobin, Christina J. Reppucci
Neuroscience (2012) Vol. 224, pp. 70-80
Open Access | Times Cited: 69
Future pharmacological treatments for substance use disorders
Ariadna Forray, Mehmet Sofuoglu
British Journal of Clinical Pharmacology (2012) Vol. 77, Iss. 2, pp. 382-400
Open Access | Times Cited: 60
Drug addiction: An affective-cognitive disorder in need of a cure
Liana Fattore, Marco Diana
Neuroscience & Biobehavioral Reviews (2016) Vol. 65, pp. 341-361
Closed Access | Times Cited: 49
Involvement of orexinergic system in psychiatric and neurodegenerative disorders: A scoping review
Hayder M. Al‐kuraishy, MayH Abdulhadi, NawarR Hussien, et al.
Brain Circulation (2020) Vol. 6, Iss. 2, pp. 70-70
Open Access | Times Cited: 44
Page 1 - Next Page

Scroll to top